Cancer Genetics Secures $5,500,000 New Financing Round

Feed Type
Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa45273c-9efb-41e6-92e5-86be982dbeb0
Date
12/7/2016
Company Name
Cancer Genetics
Mailing Address
133 Southcenter Court Rutherford, NC 27560 USA
Company Description
Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China.
Website
http://www.cancergenetics.com
Transaction Type
Venture Equity
Transaction Amount
$5,500,000
Transaction Round
Undisclosed
Proceeds Purposes
Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing.
M&A Terms
Venture Investor
Undisclosed